Introduction
Epidemiological studies continue to support the premise that dietary intake of Allium vegetables, especially garlic, may offer protection against the risk of different types of malignancies including cancer of the prostate (1) (2) (3) (4) . For example, Hsing et al. (4) examined the association between Allium vegetable intake and prostate cancer risk in a population-based study involving 238 histologically confirmed cases and 471 controls. The risk of prostate cancer was found to be significantly lower in men consuming 410 g/day of total Allium vegetables than in men with total Allium vegetable intake of 52.2 g/day (4) . Laboratory studies indicate that anticarcinogenic effect of Allium vegetables is because of organosulfur compounds (OSCs) that are generated upon processing (cutting or chewing) of these vegetables (5, 6) .
Garlic-derived OSCs including diallyl sulfide, diallyl disulfide (DADS) and diallyl trisulfide (DATS) have been shown to offer significant protection against cancer in animal models induced by a variety of chemical carcinogens (7) (8) (9) (10) (11) (12) (13) . For example, cancer prevention by naturally occurring OSC analogs has been observed against dimethylhydrazineinduced colon cancer in rats, benzo[a]pyrene-induced forestomach and pulmonary carcinogenesis in mice, azoxymethaneinduced colon cancer in rats, and N-methyl-N-nitrosourea and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced mammary cancer in rats (7) (8) (9) (10) (11) (12) (13) . Prevention of chemically induced cancers in animal models by OSCs is believed to be owing to their ability to increase detoxification of activated carcinogenic metabolites through induction of Phase II enzymes such as glutathione transferases and/or inhibit carcinogen activation through inhibition of Phase I enzymes (14) (15) (16) (17) . In addition, oral administration of DADS significantly suppresses growth of H-ras oncogene transformed NIH 3T3 tumor xenografts in athymic mice by inhibiting membrane association of p21 H-ras (18, 19) . Evidence is accumulating to indicate that certain naturally occurring OSC analogs can inhibit proliferation of cultured cancer cells by causing cell-cycle arrest and apoptosis induction (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . For example, DADS inhibited proliferation of HCT-15 human colon cancer cells by causing G 2 -M phase cell-cycle arrest in association with accumulation of cyclinB1, reduced complex formation between cyclin-dependent kinase 1 (Cdk1) and cyclinB1, and hyperphosphorylation (inactivation) of Cdk1 (21, 22) . We have shown recently that the DATS-induced cell-cycle arrest in human prostate cancer cells is mediated by reactive oxygen species (ROS) and is associated with activation of checkpoint kinase 1 (30) (31) (32) . The DADS-induced apoptosis in HCT-15 cells was shown to correlate positively with an increase in the level of intracellular free calcium (20) . The DADS-induced cell death in MDA-MB-231 human breast cancer cell line was attributed to induction of Bax, downregulation of Bcl-xL and activation of caspase 3 (23) . In spite of these advances, the mechanism(s) by which garlic-derived OSCs cause cell death is not fully defined. This knowledge is essential for further development of OSCs as clinically useful anticancer agents.
We have shown recently that DATS-induced cell death in PC-3 and DU145 cells is associated with c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)-mediated phosphorylation of Bcl-2 (29) . However, pharmacological inhibition of these kinases offers only partial protection against the cell death caused by DATS (29) . Moreover, ectopic expression of Bcl-2, through stable transfection in PC-3 cells, confers partial resistance to DATS-induced cell death (29) . These results suggested involvement of additional mechanism(s) in DATS-induced apoptosis. Here, we provide experimental evidence to indicate that DATS-induced apoptosis in PC-3 and DU145 cells is mediated by inactivation of Akt leading to mitochondrial translocation of BAD (a proapoptotic protein) and activation of caspases 3 and 9. Cell culture and cell survival assay Monolayer cultures of PC-3 and DU145 cell lines were maintained as described by us previously (29, 30) . Effect of DATS on cell survival was determined by sulforhodamine B assay as described previously (29) . Stock solution of DATS was prepared in dimethyl sulfoxide (DMSO) and an equal volume of DMSO (final concentration 0.2%) was added to the controls.
Materials and methods

Reagents
Immunoblotting
Desired cell line was treated with DATS for specified time period and lysed as described previously (29, 30) . Cell lysate was cleared by centrifugation at 21 000 g for 15 min. Supernatant proteins were resolved by sodium-dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membrane. After blocking with 5% (w/v) non-fat dry milk solution in Tris buffered saline containing 0.05% Tween-20, the membrane was incubated with the desired primary antibody for 1 h at room temperature. The membrane was then treated with appropriate secondary antibody, and the immunoreactive bands were visualized using enhanced chemiluminescence method. Membrane was stripped and reprobed with anti-actin antibody to ensure equal protein loading. Change in protein level was determined by densitometric scanning of the immunoreactive bands followed by correction for actin loading control.
Akt kinase assay
Akt kinase assay was performed using reagents supplied by the manufacturer (Cell Signaling Technology). Briefly, 2 Â 10 6 cells were plated and allowed to attach by overnight incubation. The cells were then treated with 40 mM DATS for specified time period and lysed with a solution containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride. Equal amounts of lysate proteins (200 mg) from control and DATS-treated PC-3 or DU145 cells were incubated overnight at 4 C with agarose-coupled anti-Akt antibody. Immunoprecipitated complexes were washed four times with the lysis buffer and twice with kinase buffer [25 mM Tris (pH 7.5), 5 mM b-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na 3 VO 4 and 10 mM MgCl 2 ]. The immunoprecipitates were resuspended in 40 ml of kinase buffer supplemented with 200 mM of ATP and 1 mg of GSK-3a/b fusion protein. After incubation at 30 C for 30 min, the kinase reaction was terminated with the addition of 40 ml of 2Â SDS sample buffer. An aliquot (30 ml) was subjected to immunoblotting and probed with anti-phospho-(Ser 21/9 )-GSK-3a/b antibody. Immunoprecipitation PC-3 or DU145 cells were treated with DATS and lysed as described above. Equal amounts of lysate proteins (200 mg) from control and DATS treated PC-3 or DU145 cells were incubated with 4 mg anti-14-3-3b antibody overnight at 4 C with gentle shaking. Protein A-agarose (50 ml, Santa Cruz Biotechnology) was then added to each sample, and the incubation was continued for an additional 3 h at 4 C. The immunoprecipitates were washed five times with lysis buffer and subjected to SDS-PAGE followed by immunoblotting using anti-BAD or anti-14-3-3b antibody. In another experiment, immunoprecipitation was performed using anti-IGF-1R antibody followed by immunoblotting using anti-phospho-tyrosine antibody.
Immunofluorescence analysis for mitochondrial localization of BAD PC-3 cells (2 Â 10 5 ) were plated on coverslips, and treated with 40 mM DATS or DMSO (control) for 4 h. The cells were then treated for 1 h with 100 nM mitochondria-specific dye MitoTracker Red (Molecular Probes, Eugene, OR) at 37 C. After washing with phosphate buffered saline (PBS), the cells were fixed with 3% paraformaldehyde and permeabilized using 0.1% Triton X-100. After blocking with normal goat serum (1:20 dilution) diluted with 0.5% bovine serum albumin (BSA) and 0.15% glycine in PBS (BSA buffer) for 45 min, the cells were treated with anti-BAD antibody (1:400 dilution) for 2 h. Subsequently, the cells were incubated with Alexa Fluor 488-conjugated secondary antibody (1:1000 dilution) for 1 h. After washing with BSA buffer, the cells were treated with 10 ng/ml 4 0 ,6-diamidino-2-phenylindole (DAPI) for 1 min to stain DNA. Cells were washed with PBS, mounted and photomicrographs were obtained using a Leica DC300F fluorescence microscope.
Transient transfection DU145 cells were transiently transfected with pCMV6 vector containing constitutively active Akt1 (Myr-Akt1-HA; kindly provided by Dr Daniel Altschuler, University of Pittsburgh, PA) or empty vector using LipofectamineÔ 2000 (Invitrogen, Carlsbad, CA). Briefly, DU145 cells were plated at a density of 2 Â 10 5 cells/ml and allowed to attach overnight. Cells were transfected with expression constructs encoding the constitutively active Akt or empty vector. After 6 h, the medium was replaced with fresh complete medium, and the cells were treated with 40 or 80 mM DATS or DMSO (control) for 8 h. The cells were collected and processed for cell survival assay or apoptosis assay.
Apoptosis assay
Apoptosis induction in DATS treated PC-3 or DU145 cell line was assessed by analysis of cytoplasmic histone associated DNA fragmentation. Briefly, 10 4 cells were plated in 96-well plates and allowed to attach by overnight incubation. The cells were then exposed to desired concentrations of DATS for specified time period. Cytoplasmic histone-associated DNA fragmentation was determined using a kit from Roche Diagnostics GmbH (Mannheim, Germany) according to the manufacturer's instructions.
Results
DATS inhibited Akt kinase activity
Our previous study indicated that JNK and ERKmediated phosphorylation of Bcl-2 alone cannot fully account for DATS-induced apoptosis in PC-3 or DU145 human prostate cancer cells (29) . In the present study, we used the same cell lines to test whether DATS-induced apoptosis was mediated by inactivation of Akt, a kinase known to promote cell survival and block apoptosis (33, 34) . Initially, we determined the effect of DATS treatment on activating phosphorylations of Akt (Ser  473 and Thr  308 ) by immunoblotting, and the results are shown in Figure 1A . The levels of Ser 473 and Thr 308 phosphorylated Akt were reduced rapidly on treatment of PC-3 cells with 40 mM DATS, a concentration that reduces PC-3 cell viability by 480% (29) but minimally affects proliferation of a normal prostate epithelial cell line (PrEC) (30) . However, DATS treatment did not alter the level of total Akt protein (data not shown). Treatment of PC-3 cells with 40 mM DATS for 1 and 4 h resulted in an $39 and 68% reduction in Akt kinase activity, respectively, compared with control ( Figure 1B To test whether DATS-mediated inactivation of Akt was unique to the PC-3 cell line, we determined the effect of DATS treatment on Ser 473 phosphorylation and kinase activity of Akt using DU145 prostate adenocarcinoma cells. Similar to PC-3 cells, the Ser 473 phosphorylation of Akt was reduced by $30-50% on treatment of DU145 cells with DATS when compared with control ( Figure 2A) . The DATS-mediated suppression of Akt phosphorylation in DU145 cells was coupled to a marked inhibition in the kinase activity of Akt ( Figure 2B ). The Ser 155 phosphorylation of BAD was also reduced in DU145 cells on treatment with 40 mM DATS ( Figure 2C ). These results indicated that DATS-mediated inactivation of Akt as well as dephosphorylation of BAD was not restricted to the PC-3 cell line.
DATS downregulated IGF-1R protein expression
Activation of Akt is mediated by receptor tyrosine kinases (e.g. IGF-1R) which, upon ligand binding, are autophosphorylated and cause activation of phosphatidylinositide-3 0 -kinase (36, 37) . Activated phosphatidylinositide-3 0 -kinase generates lipid second messengers, which facilitate recruitment of Akt to the plasma membrane for its activation (37) . To gain insights into the mechanism of suppression of Akt kinase in our model, we determined the effect of DATS treatment on IGF-1R protein level by immunoblotting. As can be seen in Figure 3A , DATS treatment (40 mM) caused a rapid and marked decrease in the level of IGF-1R protein in PC-3 cells, which was coupled to a reduction in autophosphorylation of IGF-1R ( Figure 3B ). The protein level of 85 kDa regulatory subunit of phosphatidylinositide-3 0 -kinase was also reduced in DATS-treated PC-3 cells ( Figure 3C ). These results suggested that the DATS-mediated inactivation of Akt may be owing to downregulation of IGF-1R protein level and inhibition of its autophosphorylation.
DATS treatment reduced interaction between BAD and 14-3-3b
The proapoptotic activity of BAD is regulated by phosphorylation (35) . In its dephosphorylated state, BAD is localized to the outer mitochondrial membrane where it binds to and antagonizes pro-survival Bcl-2 family proteins such as Bcl-xL (38, 39) . Growth factor-mediated phosphorylation of BAD causes its cytoplasmic sequestration owing to increased binding with 14-3-3 proteins, which prevents interaction of BAD with antiapoptotic Bcl-2 family members (39) (40) (41) (42) (43) . To test whether DATS treatment affected interaction between BAD and 14-3-3 proteins, we immunoprecipitated 14-3-3b using lysates from 
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DMSO-treated control and DATS-treated (40 mM, 4 h) cells, and the immunoprecipitated complexes were then subjected to immunoblotting using anti-BAD antibody. As shown in Figure 4A , the complex formation between BAD and 14-3-3b was reduced markedly in DATS-treated PC-3 and DU145 cells. The same blot was reprobed with anti-14-3-3b antibody to ensure equal immunoprecipitation from control and DATS treated lysates ( Figure 4A ).
DATS promoted mitochondrial translocation of BAD
Because DATS treatment reduced the interaction between 14-3-3b and BAD (Figure 4) , we tested the possibility whether DATS promoted translocation of BAD to the mitochondria. Figure 4B depicts merged images for BAD (green fluorescence), mitochondrial (red fluorescence) and nuclear DNA staining (blue fluorescence) in representative cells from DMSO treated control and DATS treated PC-3 cultures. In DMSO treated controls, a large fraction of mitochondria were stained red and the BAD immunostaining was predominant in the cytoplasm ( Figure 4B ). The mitochondria of a large fraction of DATS treated PC-3 cells were stained yellow-orange due to merge of red and green fluorescence indicating mitochondrial translocation of BAD ( Figure 4B ). Higher magnification was necessary to observe these effects, and thus representative data from a single cell are shown in Figure 4B . Collectively, these results indicated that DATS-mediated inactivation of Akt was associated with dephosphorylation and mitochondrial translocation of BAD.
Ectopic expression of constitutively active Akt conferred significant protection against DATS-induced apoptosis Next, we determined the effect of overexpression of constitutively active Akt on DATS-induced cell death using DU145 cells. Cells transfected with the empty vector were used as controls. Overexpression of constitutively active Akt (CAAkt) in transfected cells was confirmed by immunoblotting using antibodies against total Akt and phospho-(Ser 473 )-Akt ( Figure 5A ). In vector-transfected DU145 cells, the DATS treatment (40 and 80 mM for 8 h) caused a statistically significant increase in cytoplasmic histone-associated DNA fragmentation (a measure of apoptotic cell death) compared with vehicle treated control. However, the DATS-induced cytoplasmic histone-associated DNA fragmentation was not observed in DU145 cells overexpressing constitutively active Akt ( Figure 5B ). Consistent with these results, sulforhodamine B assay revealed that the cells transfected with CA-Akt were resistant to cell killing by DATS, whereas DATS treatment caused a dose-dependent and statistically significant reduction in survival of vector-transfected DU145 cells ( Figure 5C ).
Caspase inhibitors attenuated DATS-induced apoptosis in PC-3 and DU145 cells
We have shown previously that DATS treatment causes cleavage of caspase 3 in PC-3 cells (29) . To further examine caspase dependence in our model, we determined the effects of zVADfmk (a pan caspase inhibitor) and zLEHD-fmk (a caspase 9 specific inhibitor) on DATS-induced cleavage of caspase 3. As can be seen in Figure 6A , a 24 h treatment of PC-3 cells with Ã , P 5 0.05, significantly different compared with DMSO treated control by one-way ANOVA followed by Dunnett's test. Immunoblotting for cleaved caspase 3 and cleaved PARP using lysates from PC-3 cells treated with DATS and/or caspase inhibitors (zVAD-fmk or zLEHD-fmk). PC-3 cells were pretreated for 2 h with 40 mM zVAD-fmk or zLEHD-fmk and then exposed to 40 mM DATS for 24 h in the presence of the inhibitor. Cell lysates were prepared, and used for immunoblotting using antibodies specific for detection of cleaved caspase 3 and cleaved PARP. The blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. (B) Cytoplasmic histone associated DNA fragmentation in PC-3 (white bars) and DU145 (shaded bars) cells treated with 40 mM DATS (24 h) and/or 40 mM zVAD-fmk or zLEHD-fmk. Data are mean AE SE (n ¼ 3). a, P 5 0.05, significantly different compared with DMSO treated control; and b, P 5 0.05, significantly different compared with DATS alone treatment group by one-way ANOVA followed by Bonferroni's multiple comparison test.
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40 mM DATS resulted in cleavage of procaspase 3 as evidenced by appearance of 19 kDa cleaved intermediate. The DATS-induced cleavage of procaspase 3 was blocked in the presence of 40 mM pan caspase inhibitor zVAD-fmk and caspase 9 specific inhibitor zLEHD-fmk. The DATS-induced cleavage of PARP, a substrate of activated caspase 3, was significantly blocked in the presence of zVAD-fmk and zLEHD-fmk. Similar inhibitory effects of zVAD-fmk and zLEHD-fmk on DATS-induced cleavage of caspase 3 and PARP were also observed in DU145 cells (results not shown). Consistent with these results, the DATS-induced apoptosis, judged by analysis of cytoplasmic histone-associated DNA fragmentation, was significantly attenuated in the presence of zVAD-fmk and zLEHD-fmk in both cell lines ( Figure 6B ). These results indicated that DATS-induced apoptosis in PC-3 and DU145 cells was mediated by activation of caspases 9 and 3, and that DATS-induced apoptosis was inhibited in the presence of caspase inhibitors.
Discussion
The present study was undertaken to investigate possible involvement of Akt in apoptosis induction by DATS. The rationale for examining the effect of DATS on Akt signaling axis was based on the following considerations: (i) the DATSinduced apoptosis in PC-3/DU145 cells was not fully rescued either by pharmacological inhibition of JNK or ERK or by forced expression of Bcl-2 (29), (ii) Akt modulates the function of numerous proteins involved in the regulation of cell survival, cell-cycle progression and cell death (reviewed in Ref. 37 ), (iii) Akt activation has been observed in spontaneously developing tumors of a transgenic mouse model of prostate cancer (TRAMP mouse) (44) and (iv) Akt inactivation is implicated in regulation of apoptosis by agents including a cruciferous vegetable-derived cancer chemopreventive agent indole-3-carbinol (45, 46) . The present study reveals that DATS treatment causes a rapid decrease in activating phosphorylations of Akt (Ser  473 and Thr   308 ) in both PC-3 and DU145 cells. The Ser 473 and Thr 308 phosphorylation of Akt occurs in response to growth factor stimulus and is necessary for maximal activation of Akt (36, 37, 47) . The DATS-mediated suppression of Akt phosphorylation in PC-3 and DU145 cells is coupled to inhibition of the kinase activity of Akt as judged by immunoprecipitation kinase assay. Relative resistance of DU145 cells transfected with constitutively active Akt towards DATS-induced apoptosis compared with vector transfected controls ( Figure 5 ) further supports that Akt inactivation contributes to the cell death caused by DATS. However, further studies are needed to probe into the question whether the association between DATS-mediated Akt inactivation and cell death is unique to the prostate cancer cells.
Activated Akt can phosphorylate several apoptosis regulating proteins including pro-apoptotic Bcl-2 family member BAD (37, (48) (49) (50) . BAD promotes cell death by interacting with anti-apoptotic Bcl-2 members such as Bcl-xL, which allows the multidomain pro-apoptotic Bcl-2 family members Bax and Bak to aggregate and cause release of apoptogenic molecules (e.g. cytochrome c) from mitochondria to the cytosol culminating into caspase activation and cell death (51, 52) . Growth factor-stimulated phosphorylation of BAD at Ser 112 , Ser 136 and/or Ser 155 induces a conformational change in BAD that reduces its ability to interact with Bcl-xL (39-43).
However, phosphorylation of BAD promotes its interaction with 14-3-3 proteins, which sequesters BAD in the cytoplasm (41) (42) (43) . The present study indicates that DATS-mediated inactivation of Akt in our model is associated with reduced Ser 136 and Ser 155 phosphorylation of BAD. We also found that DATS treatment reduces interaction between BAD and 14-3-3b as revealed by immunoprecipitation-immunoblotting experiment ( Figure 4A ) leading to mitochondrial localization of BAD.
Activated Akt can also phosphorylate apoptosis signalregulating kinase 1 (Ask-1) at Ser 83 resulting in inhibition of Ask-1 activity (53). Ask-1 acts upstream of JNK and p38 mitogen-activated protein kinase (MAPK) (54) . DATSmediated inactivation of Akt in our model is likely to relieve Ask-1 phosphorylation resulting in activation of JNK and/or P38 MAPK. It is interesting to note that DATS treatment causes rapid and sustained activation of JNK, but not P38 MAPK, in both PC-3 and DU145 cells (29) . Activation of JNK in response to treatment with other naturally occurring OSC analogs has also been reported (26, 27) . Thus, it is possible that the DATS-mediated JNK activation in PC-3 and DU145 cells (29) may be linked to reduced Ser 83 phosphorylation of Ask-1. However, further studies are needed to experimentally verify this possibility.
Activation of caspases leads to cleavage and inactivation of key cellular proteins such as PARP. We showed previously that DATS treatment caused cleavage of caspases 9 and 3 in PC-3 cells (29) . In the present study, we extended these observations and determined the role of caspases 9 and 3 in DATS-induced apoptosis using PC-3 and DU145 cells. The DATS-induced cleavage of caspase 3 and PARP is significantly blocked on pretreatment with both pan caspase inhibitor and caspase 9 specific inhibitor ( Figure 6A ). Because DATSinduced apoptosis is also significantly attenuated in the presence of zVAD-fmk and zLEHD-fmk ( Figure 6B ), we postulate involvement of intrinsic caspase cascade in cell death caused by DATS.
Recent studies from our laboratory have indicated that the initial signal for cellular effects of DATS (apoptosis and cellcycle arrest) is derived from generation of reactive oxygen species (29, 30 ). This conclusion is based on the following observations: (i) DATS treatment causes generation of ROS in both PC-3 and DU145 cells (30) , (ii) the DATS-induced activation of JNK, but not ERK, is significantly blocked by adenovirus-mediated overexpression of H 2 O 2 scavenger catalase (29) , (iii) catalase overexpression offers significant protection against DATS-induced cell death (29) and (iv) the DATS-induced destruction of cell-cycle regulatory protein Cdc25C, hyperphosphorylation of Cdc25C at Ser216 and G 2 /M phase cell-cycle arrest is significantly attenuated in the presence of N-acetylcysteine, a well-known antioxidant (30) . Involvement of ROS in cellular effects of DADS, an analog of DATS, has also been postulated in other cellular systems (26, 27) . However, the precise mechanism by which DATS or other OSC analogs cause formation of ROS remains to be elucidated.
The DATS-induced apoptosis and cell-cycle arrest in prostate cancer cells have been observed at 20-40 mM concentrations (29) (30) (31) (32) . It is unclear if such concentrations of DATS are achievable in humans owing to lack of pharmacokinetic data. The pharmacokinetic parameters for S-allylcysteine, a water soluble OSC analog, have been determined in rodents and dogs (55) . The plasma concentrations following oral administration D.Xiao and S.V.Singh of 12.5, 25 and 50 mg S-allylcysteine/Kg body wt were $50, 112 and 227 mM, respectively (55) . Detailed pharmacokinetic evaluation of DATS in rodent models and humans is necessary for its further development as a potential chemopreventive or therapeutic agent.
In conclusion, the present study demonstrates that DATS treatment inactivates Akt to relieve BAD phosphorylation, which leads to reduced interaction between BAD and 14-3-3b and mitochondrial translocation of BAD. To the best of our knowledge, the present study is the first published report to link modulation of Akt signaling axis in cell death caused by a naturally occurring OSC analog.
